Condition
Appendiceal Adenocarcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Appendiceal Adenocarcinoma clinical trials that are recruiting, in United States. By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest Appendiceal Adenocarcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Paclitaxel given inside the abdomen with systemic therapy for GI cancers with peritoneal spread | Phase 2 | Orange, California | Recruiting | Aug 31, 2026 |
| TLR9-based immunotherapy for peritoneal cancer with ascites | Phase 1 | Providence, Rhode Island | Recruiting | Jun 18, 2026 |
| Molecular profiling to improve risk stratification in appendiceal cancer | — | Durate, California | Recruiting | May 14, 2026 |
| Using blood tests to personalize chemotherapy for colorectal and appendiceal cancer patients | — | Houston, Texas | Recruiting | Jul 17, 2023 |
| Investigating the genetics of appendix cancer | — | Nashville, Tennessee | Recruiting | Feb 21, 2023 |
All recruiting trials (5)
-
Paclitaxel given inside the abdomen with systemic therapy for GI cancers with peritoneal spread
This phase II study tests a combination of intraperitoneal and systemic chemotherapy (paclitaxel) in adults with digestive tract cancers that have spread to the peritoneum.
-
TLR9-based immunotherapy for peritoneal cancer with ascites
This trial tests ACM-CpG injections into the abdomen to see if it’s safe and can help people with peritoneal metastases or malignant ascites from colorectal or appendiceal cancer.
-
Molecular profiling to improve risk stratification in appendiceal cancer
Researchers test DNA methylation and m6A epitranscriptomic features in archived appendiceal cancer tissue to see if molecular subtypes and risk scores can better predict outcomes.
-
Using blood tests to personalize chemotherapy for colorectal and appendiceal cancer patients
This study is testing if blood tests that check for tumor DNA can help doctors personalize chemotherapy for patients with colorectal or appendiceal cancer to improve their chances of staying cancer-free after surgery.
-
Investigating the genetics of appendix cancer
This study is trying to find out how genetics might play a role in appendix cancer by following adults with the disease for up to six years.
Related topics
Quick answers
How many Appendiceal Adenocarcinoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.